WASHINGTON, Oct 26 (Reuters) - The U.S. Food and Drug Administration has delayed a meeting of its advisory panel to discuss Perrigo Co Plc's (PRGO.N) over-the-counter (OTC) contraceptive, the drugmaker said on Wednesday.
Black Hot Fire Network
March 29, 2024